As MeCP2 has widespread effects on gene expression, especially in neurological disease such as Rett syndrome [77], over-expressed Hmgn1 will down-regulate MeCP2 expression, which may cause disruption in terms of downstream gene expression that is necessary for normal brain development. Here, HMGN1 is linked to nervous system disorder.